Protagen, Gustave Roussy Collaborating on Markers for Immunotherapy Side Effects – GenomeWeb
|
Protagen, Gustave Roussy Collaborating on Markers for Immunotherapy Side Effects
GenomeWeb NEW YORK (GenomeWeb) – Protagen said today it has entered a collaboration with the Gustave Roussy Institute of Oncology to identify biomarkers for immune system-related side effects in cancer patients treated with checkpoint inhibitors. Under the … |
